Inogen Inc risk profile

38 Normal where most of the sector sits

Measured 1 September 2026 from INGN's filed statements. Recomputed nightly.

38 (Normal), driven by Cash conversion at 94, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation61StretchedStableOne-year price volatility — 43.1%
Operating pressure14ContainedEasingCosts outgrowing revenue — -5.8 percentage points
Cash conversion94AcuteWorseningCapital spending against operating cash — -0.22x
Leverage and coverage6ContainedEasingCurrent ratio — 3.12x
Competitive position42ElevatedStableRevenue-growth gap against peers — -24.4 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Inogen Inc